Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

4 Stocks Under $5 Insiders Are Aggressively Buying

Published 18/04/2022, 13:48
© Reuters.  4 Stocks Under $5 Insiders Are Aggressively Buying

US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Black Diamond Therapeutics

  • The Trade: Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) 10% owner BB Biotech Ag acquired a total of 252,556 shares at an average price of $3.48. To acquire these shares, it cost $879.82 thousand.
  • What’s Happening: Wedbush, last month, downgraded Black Diamond Therapeutic from Outperform to Neutral.
  • What Black Diamond Therapeutics Does: Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies.
  • The Trade: Hemisphere Media Group, Inc. (NASDAQ: HMTV) 10% owner Debra Fine acquired a total of 215,094 shares at an average price of $4.14. The insider spent around $890.02 thousand to buy those shares.
  • What’s Happening: Hemisphere Media, last month, posted Q4 sales of $56.80 million.
  • What Hemisphere Media Group Does: Hemisphere Media Group Inc is a Spanish-language media company. It owns and operates several Spanish-language networks and content production platform, including movie and telenovela channels, Hispanic entertainment genres, and the cable television networks.

Don’t forget to check out our premarket coverage here .

ReWalk Robotics

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
  • The Trade: ReWalk Robotics Ltd. (NASDAQ: RWLK) 10% owner Lind Global MacRo Fund Lp acquired a total of 242,251 shares at an average price of $2.35. To acquire these shares, it cost around $569.37 thousand.
  • What’s Happening: ReWalk Robotics, during February, posted Q4 sales of $1.20 million.
  • What ReWalk Robotics Does: ReWalk Robotics Ltd is an Israel based medical device company.
  • The Trade: OncoCyte Corporation (NASDAQ: OCX) 10% owner Broadwood Capital Inc acquired a total of 6,003,752 shares at an average price of $1.33. The insider spent $8 million to buy those shares.
  • What’s Happening: Oncocyte recently reported pricing of registered direct offering of 11.765 million shares.
  • What OncoCyte Does: OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.